These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII. Fratzl-Zelman N, Morello R, Lee B, Rauch F, Glorieux FH, Misof BM, Klaushofer K, Roschger P. Bone; 2010 Mar; 46(3):820-6. PubMed ID: 19895918 [Abstract] [Full Text] [Related]
6. Treatment of poor linear growth in a patient with osteogenesis imperfecta type III. Robinson RF, Long LD, Mahan JD. Clin Ther; 2004 Oct; 26(10):1680-3. PubMed ID: 15598484 [Abstract] [Full Text] [Related]
7. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study. Allen DB. J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612 [Abstract] [Full Text] [Related]
8. Children with severe Osteogenesis imperfecta and short stature present on average with normal IGF-I and IGFBP-3 levels. Hoyer-Kuhn H, Höbing L, Cassens J, Schoenau E, Semler O. J Pediatr Endocrinol Metab; 2016 Jul 01; 29(7):813-8. PubMed ID: 27089405 [Abstract] [Full Text] [Related]
12. Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone. Fratzl-Zelman N, Schmidt I, Roschger P, Roschger A, Glorieux FH, Klaushofer K, Wagermaier W, Rauch F, Fratzl P. Bone; 2015 Apr 29; 73():233-41. PubMed ID: 25554599 [Abstract] [Full Text] [Related]
13. Comparison of growth hormone responses to classical stimulation tests and to intravenous administration of growth hormone releasing factor (GRF 1-44) in children with growth hormone deficiency. Rymkiewicz-Kluczyńska B, Szarras-Czapnik M, Romer T. Endokrynol Pol; 1987 Apr 29; 38(1):9-13. PubMed ID: 3123208 [No Abstract] [Full Text] [Related]
15. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement. Letocha AD, Cintas HL, Troendle JF, Reynolds JC, Cann CE, Chernoff EJ, Hill SC, Gerber LH, Marini JC. J Bone Miner Res; 2005 Jun 29; 20(6):977-86. PubMed ID: 15883638 [Abstract] [Full Text] [Related]
16. Defective growth hormone secretion in children with pycnodysostosis and improved linear growth after growth hormone treatment. Soliman AT, Rajab A, AlSalmi I, Darwish A, Asfour M. Arch Dis Child; 1996 Sep 29; 75(3):242-4. PubMed ID: 8976667 [Abstract] [Full Text] [Related]
17. Growth, short stature, and the use of growth hormone: considerations for the practicing pediatrician--an update. Schwartz ID, Grunt JA. Curr Probl Pediatr; 1997 Jan 29; 27(1):14-40. PubMed ID: 9111702 [No Abstract] [Full Text] [Related]
18. Physical growth in Brachmann-de Lange syndrome. Kousseff BG, Thomson-Meares J, Newkirk P, Root AW. Am J Med Genet; 1993 Nov 15; 47(7):1050-2. PubMed ID: 8291522 [Abstract] [Full Text] [Related]
19. Effect of prolonged clonidine administration on growth hormone concentrations and rate of linear growth in children with constitutional growth delay. Castro-Magaña M, Angulo M, Fuentes B, Castelar ME, Cañas A, Espinoza B. J Pediatr; 1986 Nov 15; 109(5):784-7. PubMed ID: 3095519 [Abstract] [Full Text] [Related]